A group of scientists has been trying to devise a method to turn cancer into its own worst foe. In new research, they have developed a new experimental vaccine for cancer that utilizes tumor cells that are altered to supply a toxic payload to the rest of the area that is cancer-stricken. Health experts who have been involved in the research have said that the new vaccine also makes it easier for the immune system to aim and recognize the cancer cells in the future as well.
The authors of recent research have claimed that= the vaccine has been able to deliver promising effects against the most standard form of brain cancer in mice. The team of scientists has noted that cancer vaccines are usually remedial which means these vaccines are able to treat existing tumors and avert the reoccurrence of cancer. As per the latest findings cancer vaccines aims to exploit a curve in cancer’s shield that usually helps cancer to dodge the immune system. More often, scientists achieve this by teaching immune cells to identify some vital parts of a cancer cell, such as cancer-specific proteins with the help of disabled cancer cells or some other distribution method. However, the authors of new research from Harvard Medical School and Brigham and Women’s Hospital have been trying a different method altogether. The new research has been led by Khalid Shah. The team plans to use living cancer cells and change them genetically into traitors.
The lead author of the research has said that the team has followed a simple approach, which is to use cancer cells and alter them genetically into cancer killers and vaccines. Khalid Shah is the chief of the Center for Stem Cell and Translational Immunotherapy at Harvard Medical School and Brigham and Women’s Hospital. Health experts have said that the team plans to deactivate the natural affinity of cancer cells to seek out their own types of cells. However, these modified remedial cancer cells, which have been termed as ThTCs, by the researchers are altered with the help of CRISPR-Cas9 in two crucial methods. Initially, the cells are supposed to yield potent cancer-killing agents. And later, they are meant to make other proteins that will attract the attention of the immune system. It preferably means that the body can organically produce long-term protection against cancer. To further confirm the efficacy of the therapy, Scientists have programmed the cells to carry out a double kill-switch, which will help them to be easily eliminated if cancer cells attempt to spread further.
The findings of the study have been released in the journal known as Science Translational Medicine. The team of scientists has said that their initial findings have been the result of the usage of the cancer vaccine against glioblastoma tumors. Glioblastoma Tumors are the most regular type and usually deadly type of brain cancer. Experts have said that the new cancer vaccine seems to be safe and potent at eliminating cancer cells and incites a robust immune retort and extends the survival of mice from various strains, including those who have been raised to have a human-like immune system. Researchers claim that their cell-based cancer vaccine might be utilized to cure and avert a wide variety of cancers in the body. They have said that they have developed the next generation of autologous and allogeneic-modified cancer cell-based shots. They are confident that their remedial strategy will have the potential to affect patients by averting cancer recurrence, growth, and metastasis. The lead author of the study has claimed that clinical trials of their new cancer vaccine might begin within three to five years.
ABOUT AUTHOR
